RxDoctor Payments Data

Jennifer Trimai

Physician Assistant · Chula Vista, CANPI 1730454091

Payments from drug & device makers

$6,579in general payments, 2019–2025

Across 300 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$1K
  • Sanofi$746
  • Incyte Corporation$440
  • E.r. Squibb & Sons, L.L.C.$342
  • Dermavant Sciences, Inc.$334
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,25495%
  • Education$3255%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,579 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab54$206,115
OpzeluraRuxolitinib Phosphate97$187,452
Taltz AutoinjectorIxekizumab12$81,329
Humira PenAdalimumab11$74,889
ZoryveRoflumilast44$36,532
VtamaTapinarof25$34,100
Betamethasone Dipropionate216$7,439
Clobetasol Propionate141$7,093
Ketoconazole343$6,649
Tacrolimus34$5,022
Triamcinolone Acetonide191$3,238
Pimecrolimus11$2,670
Fluorouracil38$2,627
Fluocinonide44$2,146
Metronidazole35$1,891

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationOpzelura$440$187,45297 claims
Arcutis Biotherapeutics, Inc.Zoryve$79$36,53244 claims
Dermavant Sciences, Inc.Vtama$334$34,10025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →